Abstract Details

Title Comparison of Metabolic Profiles of Newer Second Generation Antipsychotics

Topic General Neurology

Presentation(s) P5 - (-)

Poster/Presentation
Number 335

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Traci Aladeen, PharmD (Dent Neurologic Institute) PRESENTER	Dr. Aladeen has nothing to disclose.
	No disclosure on file
Michelle Rainka, PharmD (Dent Neurologic Institute)	Dr. Rainka has stock in Abbvie. Dr. Rainka has stock in acadia. Dr. Rainka has stock in alon. Dr. Rainka has stock in biogen. Dr. Rainka has stock in bristol myers squib. Dr. Rainka has stock in eisai. Dr. Rainka has stock in Lilly. Dr. Rainka has stock in novartis. Dr. Rainka has stock in pfizer. Dr. Rainka has stock in roche. Dr. Rainka has stock in Sage. Dr. Rainka has stock in alkermes.
	No disclosure on file
Francis M. Gengo, PharmD (Dent Neurologic Institute)	No disclosure on file
Horacio Capote, MD (Dent Neurologic Group, LLP)	No disclosure on file